Stay updated on STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page.

Latest updates to the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe site revision identifier in the footer changed from v3.7.0 to v3.7.1; the page remains a 403 error.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page now displays a 403 Forbidden error with a standard header and a Home link, indicating the study record is currently blocked from access.SummaryDifference19%

- Check31 days agoChange DetectedThe page shows a revision update from v3.6.6 to v3.7.0, indicating a newer build of the ClinicalTrials.gov page. No substantive study details appear to be altered in this update.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page's revision history now includes Revision: v3.6.6 and removes Revision: v3.6.5, reflecting a small backend or page-tracking update rather than new study information.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page's revision tag was updated from v3.6.4 to v3.6.5, indicating a new build of the page. This is a routine maintenance update that does not change study details or how the page works.SummaryDifference0.1%

- Check80 days agoChange DetectedThe page now shows Revision: v3.6.4 instead of v3.6.3. This appears to be a minor site/template update and does not modify study data.SummaryDifference0.1%

Stay in the know with updates to STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page.